Bio­gen can't es­cape co­pay kick­back law­suits as Hu­mana al­leges 'seed­ing and sweep­ing' scheme

4 years ago
Pharma

Bio­haven turns out a dud in fa­tal neu­rode­gen­er­a­tive dis­ease, cast­ing doubt on drug's chances in ALS

4 years ago
R&D

Mer­ck touts a con­fir­ma­to­ry Keytru­da win for liv­er can­cer as 'dan­gling' ac­cel­er­at­ed ap­proval saga march­es on

4 years ago
R&D
Pharma

No­vo Nordisk set­tles in­sulin pric­ing suit for $100M

4 years ago
Pharma

A new psy­che­delics play­er emerges to treat men­tal health dis­or­ders — mi­nus the hal­lu­cino­genic ef­fects

4 years ago
Financing

Covid-19 roundup: Nor­mal life is in sight, but not with­out fur­ther vac­ci­na­tions — Bourla; For the 3rd time, EU ...

4 years ago
Coronavirus

Mer­ck, Pfiz­er end patent feud over pneu­mo­coc­cal vac­cines with roy­al­ty-cen­tered set­tle­ment

4 years ago
Pharma

The coro­n­avirus vac­cine that the world for­got could still help save it

4 years ago
Coronavirus
In Focus

DE­VEL­OP­ING News: Ac­celeron ne­go­ti­at­ing $11B buy­out; 11 promis­ing biotech star­tups; Changes ga­lore at No­var­tis; ...

4 years ago
Weekly

Days of heat­ed ru­mors cul­mi­nate in a re­port that Ac­celeron is in ad­vanced buy­out talks

4 years ago
Deals
R&D

New ARIA cas­es dog Bio­gen's Aduhelm launch in an­oth­er po­ten­tial blow to block­buster hopes — an­a­lyst

4 years ago
FDA+

Capri­cor's DMD clin­i­cal tri­al meets pri­ma­ry end­points; Delaware court rules against Take­da in Lupron feud

4 years ago
News Briefing

Trevor Bed­ford, Cigall Kadoch among this year's in­com­ing HH­MI in­ves­ti­ga­tors

4 years ago
People
Financing

Mi­cro­cap gene ther­a­py play­er says three chil­dren suf­fered se­ri­ous side ef­fects in PhI/II study

4 years ago
R&D
Cell/Gene Tx

Covid-19 roundup: SAB's an­ti­body treat­ments move to PhI­II; Af­ter long jour­ney, No­vavax sub­mits vac­cine to WHO for ...

4 years ago
Coronavirus

As­traZeneca and Mer­ck hope new da­ta can PRO­pel their PARP in­hibitor in­to first-line prostate can­cer

4 years ago
R&D

CDC di­rec­tor over­rules ad­vi­sors on boost­ers, rec­om­mend­ing third shots for at-risk work­ers

4 years ago
FDA+

With Mav­er­ick now in Takeda's hands, James Sci­bet­ta turns the page; Roivant CMO leaves in fa­vor of small IL-2 biotech

4 years ago
Peer Review

In step for­ward for re­ju­ve­na­tion field, re­searchers turn back the clock on mice hearts

4 years ago
Discovery

Till­man Gern­gross project out of Dart­mouth Col­lege ac­quired by Repli­gen

4 years ago
Deals
Manufacturing

Lon­za un­veils new ex­pan­sion plans at Swiss man­u­fac­tur­ing sites, cap­ping off a very busy pan­dem­ic

4 years ago
Manufacturing

Take­da breaks ground on ze­ro-emis­sion site in Asia; Boston Labs emerges from stealth with mo­bile cell, gene ther­a­py ...

4 years ago
Manufacturing

Catal­ent inks deal with Phath­om to make GI drug at re­cent­ly-ren­o­vat­ed Ken­tucky site

4 years ago
Outsourcing
Manufacturing

UNC re­searchers re­port a new way to charge CAR-T against sol­id tu­mors

4 years ago
Discovery
Cell/Gene Tx
First page Previous page 635636637638639640641 Next page Last page
A service from the Financial Times